BioTime Takes Strategic Step Forward In Developing Regenerative Technology

BioTime Takes Strategic Step Forward In Developing Regenerative Technology

  • Posted Tuesday, March 16, 2010 -
  • Share |
Tuesday, BioTime Inc. (BTIM) announced a peer-reviewed scientific publication on the reversal of developmental aging in normal human cells , taking a strategic step forward in the development of its ReCyte iPS Technology. Shares touched a new intraday high of $8.42 for the year and is trading at $7.52, an increase of nearly 30% from the previous days close.view original article

Related News Items